Nicoderm in Canada
This article was originally published in The Tan Sheet
Executive Summary
Patented Medicine Prices Review Board will hold a hearing on the price of the nicotine patch marketed by Hoechst Marion Roussel Canada. The purpose of the hearing, scheduled for July 5, is to try to determine whether HMR has sold or is selling, anywhere in Canada, Nicoderm at a price the board considers "excessive," and if so, "what order, if any, should be made." The PRPMB, a quasi-judicial body, was created in 1987 to ensure that patented drug prices are not excessive, to report annually to Parliament on price trends and the ratio of R&D expenditures to sales. Nicoderm was cleared for self-selection in Canada in 1998. For information on the hearing, contact PMPRB's Sylvie Dupont-Kirby at 877-861-2350
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning